Unlock instant, AI-driven research and patent intelligence for your innovation.

Process For Making Form I Of Olanzapine

a technology of dihydrate c and olanzapine, which is applied in the field of new dihydrate c of olanzapine, can solve the problems of difficult removal of impurity c and increase of impurity level

Inactive Publication Date: 2008-01-10
SHASUN CHEM & DRUGS LTD
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this is associated with problems of removing residual methylene chloride from the final product (limit of not more than 600 ppm) in spite of increasing drying temperatures around 70° C. for a sufficiently long time.
This impurity C is difficult to remove even upon multiple re-crystallizations from methylene chloride, and in fact the level of impurity increases with each re-crystallization, as this impurity C is a product formed by the reaction of Olanzapine in methylene chloride.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process For Making Form I Of Olanzapine
  • Process For Making Form I Of Olanzapine
  • Process For Making Form I Of Olanzapine

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Crude Olanzapine Form I

[0033] Crude Olanzapine (30.0 g) is added into dichloromethane (180 ml). The reaction mixture is refluxed at 35-40° C. for a period of 15-20 min. When complete dissolution occurs, activated carbon (1.20 g) is added and the reaction mixture is then refluxed at 35-40° C. for 15 min. The solution is then filtered through hy-flo bed and the bed is washed with dichloromethane (30 ml). The filtrate is then slowly cooled to 0-5° C. and then maintained at 0-5° C. for 5 h to complete the crystallization. The content is then filtered, washed with chilled (0-5°) dichloromethane (30 ml) and dried at 70° C.-75° C. under vacuum for 12 hours (Yield 14 g) to give Olanzapine Form I. Dichloromethane content 620 ppm. Impurity C is 0.2% w / w.

example 2

Preparation of Olanzapine Dihydrate C

[0034] Olanzapine Form—I (10 g) is suspended in water (30 ml) and stirred at 30 to 35° C. over a period of 30 minutes. The slurry is then filtered and washed with water (50 ml) and suck dried. The product obtained is dried at 30 to 35° C. for 24 hrs (Yield: 9.5 g). The moisture content of the product is 10.2%.

[0035] The product is examined by powder x-ray crystallography, infrared spectroscopy and differential scanning calorimetry to identify the crystal form (FIGS. 1 to 3). The product is examined by powder x-ray crystallography, infrared spectroscopy and differential scanning calorimetry to identify the crystal form (FIGS. 1 to 3).

example 3

Preparation of Form I of Olanzapine

[0036] The Olanzapine Dihydrate C (10 g) is dried at 60° C. to 70° C. under vacuum for 3 to 4 hours (Yield: 8.5 g) to obtain substantially pure Olanzapine Form I. The moisture content of the product is 0.2% and dichloromethane is 112 ppm. Impurity C content is 0.08% w / w. Thus it is clear that producing Olanzapine Form I by following the process as invented by the present applicant [eg. 3] results in lesser DCM content as well as lower impurity C levels.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Temperatureaaaaaaaaaa
Login to View More

Abstract

This invention discloses a new dihydrate polymorph of Olanzapine (hereinafter referred to as “dihydrate C”), and process for recovering anhydrous Form I of Olanzapine from this novel Dihydrate C.

Description

FIELD OF THE INVENTION [0001] The present invention relates to novel dihydrate C of Olanzapine, and a process for its conversion to Form I of Olanzapine. BACKGROUND OF THE INVENTION [0002] Olanzapine is an antipsychotic agent that belongs to the thienobenzodiazepine class. The chemical designation is 2-methyl-4-(4-methyl-1-piperazinyl)-1OH-thieno[2,3-b][1,5]benzodiazepine. [0003] U.S. Pat. No. 5,736,541 discloses that Olanzapine can exist in two different crystalline polymorphs namely Form I and Form II, wherein the two polymorphs are characterized by their different X-ray power diffraction pattern and are represented by the following interplanar spacings and typical relative intensities as shown in Table—1. TABLE 1X-Ray powder diffraction spectrums of Form I and Form IIForm IIForm IdI / I1dI / I19.9463100.0010.2689100.008.5777.968.557915.187.47211.418.24451.967.1256.506.886214.736.14593.126.37874.256.0715.126.24395.214.48490.525.58951.105.21816.865.30550.955.12512.474.98156.144.98747....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/551A61P25/00C07D243/12
CPCC07D495/04A61P25/00A61P25/18
Inventor THAKASHINAMOORTHY, CHANDIRANKRISHNAN, DEVARAJANGOVINDARAJU, SARAVANANJOTHI, SHOBANA
Owner SHASUN CHEM & DRUGS LTD